Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
FAQ
- What is Amphastar Pharmaceuticals's EBIT?
- Amphastar Pharmaceuticals (AMPH) reported EBIT of $39.73M in Q2 2026.
- How has Amphastar Pharmaceuticals's EBIT changed year-over-year?
- Amphastar Pharmaceuticals's EBIT decreased by 5.8% year-over-year, from $42.18M to $39.73M.
- What is the long-term trend for Amphastar Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's EBIT has grown at a 19.1% compound annual growth rate (CAGR), from $69.89M to $140.4M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Amphastar Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude